Dr. Sudhir Duvuru, MD

Dr. Duvuru practices at OhioHealth Doctors Hospital in Columbus, Ohio, part of OhioHealth.

Dr. Duvuru's NPI, 1073742672, was assigned on July 6, 2009. Dr. Duvuru holds Ohio license 35.099532.

Dr. Duvuru's primary practice is OhioHealth Doctors Hospital, at 5100 West Broad Street, Columbus, OH 43228 in Franklin County. The practice phone is (614) 544-2136.

Dr. Duvuru's primary practice is OhioHealth Doctors Hospital in Columbus, Ohio, part of OhioHealth. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Duvuru to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duvuru practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Duvuru's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Duvuru is board certified in internal medicine by the American Board of Internal Medicine. Dr. Duvuru is licensed in Ohio.

CMS data shows 316 Medicare services from Dr. Duvuru across 4 procedure codes in 2024, for 165 Medicare patients. Medicare paid $25,899 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Duvuru in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Duvuru's median patient age at 72, with 56% women.

In 2024, Dr. Duvuru wrote 249 Medicare Part D claims for 117 patients. 90% of them were for generic drugs. CMS names the drug for 65 of them, across 5 drugs with 11 or more claims each, at $279 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Duvuru for performance year 2024, reported as part of a group. Dr. Duvuru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Duvuru from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $80.